1. Home
  2. ZVIA vs NERV Comparison

ZVIA vs NERV Comparison

Compare ZVIA & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevia PBC

ZVIA

Zevia PBC

N/A

Current Price

$0.94

Market Cap

126.3M

ML Signal

N/A

NERV

Minerva Neurosciences Inc

N/A

Current Price

$2.12

Market Cap

108.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZVIA
NERV
Founded
2007
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.3M
108.6M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
ZVIA
NERV
Price
$0.94
$2.12
Analyst Decision
Strong Buy
Buy
Analyst Count
6
3
Target Price
$3.67
★ $10.33
AVG Volume (30 Days)
★ 451.5K
167.7K
Earning Date
11-04-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 55.88
N/A
EPS
★ N/A
N/A
Revenue
★ $161,259,000.00
$41,175,600.00
Revenue This Year
$9.55
N/A
Revenue Next Year
$6.45
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 4.01
N/A
52 Week Low
$0.96
$1.96
52 Week High
$2.75
$8.80

Technical Indicators

Market Signals
Indicator
ZVIA
NERV
Relative Strength Index (RSI) 36.32 34.63
Support Level N/A $1.96
Resistance Level $1.52 $2.71
Average True Range (ATR) 0.13 0.24
MACD -0.03 0.01
Stochastic Oscillator 0.53 4.17

Price Performance

Historical Comparison
ZVIA
NERV

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: